top of page

Industry Comparables

The antidepressant drug market was valued at USD 13.39 billion in 2018 and is expected to reach USD 15.88 billion by 2025

Market Cap. / Est. Valuation

Not Disclosed

$1.7B

$1.8B

$218M

$287M

$251M

Symbol

N/A

NASDAQ | CMPS

NEO | MMED

NEO | CYBN

TSX-V | NUMI

CSE | FTRPF

Company Name

ATAI Life Sciences

COMPASS Pathways

MindMed

Cybin Corp

Numinis Wellness

FieldTrip

Artboard – 7_2x.png
Pic2_edited_edited.jpg

EVAN LEVINE
Co-Founder, CEO and Director

Managing Partner

at Brown Simpson Asset Management

Chief Executive Officer – Adventrx Pharmaceuticals

DSC05532_edited_edited_edited.jpg

DR. MATTHEW MCMURRAY
Neuropsychopharmacology

Assistant Professor – Miami University

PhD Psycology University of Illinois

1594308999566_edited_edited_edited.jpg

DR. MICHAEL SPIGARELLI

Chief Medical Officer

MD - Board Certified Internal Medicine and Clinical Pharmocology

PhD Medicinal Chemistry, MBA

Chief Medical Officer - Lumen Bio

Joans.png

DR. JOAN ROBBINS
Translational Research

President – Calypharma Consulting 

Chief Scientific Officer

Adventrx Pharmaceuticals

DSC05554_edited.jpg

DR. ANDREW JONES

Inventor and Chairman,

Scientific Advisory Board

Ph.D. Chemical and Biological Engineering – RPI  Assistant Professor – Miami University

Headshot-6.png

NOAH DAVIS
Chief Financial Officer

CEO at Upstryve

CFO Corporate Management and Consulting Group

bottom of page